134 related articles for article (PubMed ID: 12480466)
41. Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment.
Tsai SJ; Yu YW; Lin CH; Wang YC; Chen JY; Hong CJ
Neuropsychobiology; 2004; 50(1):37-40. PubMed ID: 15179018
[TBL] [Abstract][Full Text] [Related]
42. Weight gain induced by clozapine.
Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW
Eur Neuropsychopharmacol; 1995 Dec; 5(4):437-40. PubMed ID: 8998394
[TBL] [Abstract][Full Text] [Related]
43. [Neuroleptic adverse effects with emphasis on weight gain].
Hebebrand J
Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):321-4. PubMed ID: 20306798
[No Abstract] [Full Text] [Related]
44. Genetic variation of 5-HT2A receptor and response to clozapine.
Masellis M; Paterson AD; Badri F; Lieberman JA; Meltzer HY; Cavazzoni P; Kennedy JL
Lancet; 1995 Oct; 346(8982):1108. PubMed ID: 7564821
[No Abstract] [Full Text] [Related]
45. Clozapine response and the 5HT2C Cys23Ser polymorphism.
Malhotra AK; Goldman D; Ozaki N; Rooney W; Clifton A; Buchanan RW; Breier A; Pickar D
Neuroreport; 1996 Sep; 7(13):2100-2. PubMed ID: 8930967
[TBL] [Abstract][Full Text] [Related]
46. Pharmacogenetics of the clozapine response.
Schumacher J; Schulze TG; Wienker TF; Rietschel M; Nöthen MM
Lancet; 2000 Aug; 356(9228):506-7. PubMed ID: 10981913
[No Abstract] [Full Text] [Related]
47. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
Opgen-Rhein C; Brandl EJ; Müller DJ; Neuhaus AH; Tiwari AK; Sander T; Dettling M
Pharmacogenomics; 2010 Jun; 11(6):773-80. PubMed ID: 20504252
[TBL] [Abstract][Full Text] [Related]
48. Serotonin-6 receptor variant (C267T) and clinical response to clozapine.
Yu YW; Tsai SJ; Lin CH; Hsu CP; Yang KH; Hong CJ
Neuroreport; 1999 Apr; 10(6):1231-3. PubMed ID: 10363930
[TBL] [Abstract][Full Text] [Related]
49. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Masellis M; Basile V; Meltzer HY; Lieberman JA; Sevy S; Macciardi FM; Cola P; Howard A; Badri F; Nöthen MM; Kalow W; Kennedy JL
Neuropsychopharmacology; 1998 Aug; 19(2):123-32. PubMed ID: 9629566
[TBL] [Abstract][Full Text] [Related]
50. Genetic variation of the 5-HT2A receptor and response to clozapine.
Nöthen MM; Rietschel M; Erdmann J; Oberländer H; Möller HJ; Nober D; Propping P
Lancet; 1995 Sep; 346(8979):908-9. PubMed ID: 7564704
[No Abstract] [Full Text] [Related]
51. Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain.
Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
J Neural Transm (Vienna); 2005 Nov; 112(11):1463-8. PubMed ID: 15795790
[TBL] [Abstract][Full Text] [Related]
52. Pharmacogenetic prediction of clozapine response.
Arranz MJ; Munro J; Birkett J; Bolonna A; Mancama D; Sodhi M; Lesch KP; Meyer JF; Sham P; Collier DA; Murray RM; Kerwin RW
Lancet; 2000 May; 355(9215):1615-6. PubMed ID: 10821369
[TBL] [Abstract][Full Text] [Related]
53. Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine.
Yu YW; Tsai SJ; Yang KH; Lin CH; Chen MC; Hong CJ
Neuropsychobiology; 2001; 43(2):79-82. PubMed ID: 11174050
[TBL] [Abstract][Full Text] [Related]
54. Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia.
Zhang ZJ; Zhang XB; Sha WW; Zhang XB; Reynolds GP
Mol Psychiatry; 2002; 7(7):670-1. PubMed ID: 12192608
[No Abstract] [Full Text] [Related]
55. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
56. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
Souza RP; Tiwari AK; Chowdhury NI; Ceddia RB; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Psychiatr Res; 2012 Apr; 46(4):462-8. PubMed ID: 22305490
[TBL] [Abstract][Full Text] [Related]
57. Pharmacogenetics in psychosis.
Collier DA
Drug News Perspect; 2003 Apr; 16(3):159-65. PubMed ID: 12819814
[TBL] [Abstract][Full Text] [Related]
58. Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis.
Gressier F; Porcelli S; Calati R; Serretti A
Eur Neuropsychopharmacol; 2016 Feb; 26(2):163-185. PubMed ID: 26792444
[TBL] [Abstract][Full Text] [Related]
59. Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.
Lee AK; Bishop JR
Pharmacogenomics; 2011 Jul; 12(7):999-1016. PubMed ID: 21787190
[TBL] [Abstract][Full Text] [Related]
60. Sleep apnea associated with antipsychotic-induced obesity.
Wirshing DA; Pierre JM; Wirshing WC
J Clin Psychiatry; 2002 Apr; 63(4):369-70. PubMed ID: 12000215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
